While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

That's how much new U.S. tariffs could cost Mercedes-Benz this year, according to brokerage Bernstein—14% of expected operating profit. That is before any potential retaliation by U.S. trading ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The secret of the president’s dramatic weight loss is the talk of the White House, our must-read newsletter The Swamp reveals.

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

A few Easter eggs too many have stopped your weight-loss goals in their tracks, but don’t allow that to cause your motivation ...

Even those using appetite-suppressing jabs such as Ozempic and Wegovy need a similar mindset, Aherne says. Such drugs may have helped people to lose up to 20 per ... cost of up to pounds 300 a month ...

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

It’s a common refrain: cable has gotten too expensive. This is why live TV streaming services have increased in popularity over the last few years. Why pay for a bunch of channels you may never ...

lower class sizes; give support to students with ADHD, dyslexia, and other disabilities; feed hungry students so they can learn; provide one-on-one tutoring; and make the cost of higher education and ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...